IQVIA said revenue for Q2 2026 was $4,368 million, up 8.7% year-over-year on a reported basis and 8.5% at constant currency. Commercial Solutions revenue was $1,793 million and Research & Development Solutions revenue was $2,575 million.

1. 01

   IQVIA said revenue for Q2 2026 was $4,368 million, up 8.7% year-over-year on a reported basis and 8.5% at constant currency. Commercial Solutions revenue was $1,793 million and Research & Development Solutions revenue was $2,575 million.

2. 02

   The company said GAAP Net Income for Q2 was $256 million and GAAP Diluted Earnings per Share was $1.53. Adjusted EBITDA was $994 million, up 9.2% year-over-year, and Adjusted Diluted Earnings per Share was $3.15, up 12.1%.

3. 03

   IQVIA said net new bookings for Q2 were $3.15 billion, up 19% year-over-year, resulting in a book-to-bill ratio of 1.22x. As of June 30, 2026, R&DS contracted backlog was $34.2 billion, and the company expects approximately $9.2 billion of this backlog to convert to revenue in the next 12 months.

4. 04

   The company is raising its full-year 2026 guidance for revenue to be between $17,275 million and $17,475 million, for Adjusted EBITDA to be between $4,000 million and $4,050 million and for Adjusted Diluted Earnings per Share to be between $12.80 and $13.00. It said the new mid-point of the revenue growth guidance is 6.5% versus the prior guidance of 5.8%.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.